Katheryn Ryan|Elizabeth Garrett?Mayer|Anthony J. Alberg|Kathleen B. Cartmell|Matthew J. Carpenter
Predictors of Cessation Pharmacotherapy Use Among Black and Non-Hispanic White Smokers
Medical University of South Carolina|MUSC Hollings Cancer Center|Medical University of South Carolina|Medical University of South Carolina|MUSC Hollings Cancer Center|MUSC Hollings Cancer Center|Medical University of South Carolina|Medical University of South Carolina|MUSC Hollings Cancer Center
use pharmacotherapy smoking cessation improves quit rates treatments underutilized particularly among black smokers attitudes toward pharmacotherapy may differ racialethnic minorities caucasian smokers hypothesized black nonhispanic white smokers would differ attitudes toward pharmacotherapy association attitudes toward actual use pharmacotherapy would differ racethe study consisted single crosssectional telephonebased survey current smokers n 697 examined relationship race attitudes toward pharmacotherapy pharmacotherapy usage representative biracial sample 39 blackblack smokers significantly less likely report ever use pharmacotherapy 23 caucasians 39 odds ratio 046 95 ci 033066 compared caucasians blacks significantly less favorable attitudes toward pharmacotherapy including disbelief efficacy p 03 addiction concerns p 03 harmfulness pharmacotherapy p 008 need treatment kind quit smoking p 004 multiple logistic regression racial group caucasian referent 055 p 003 addiction concerns 080 p 01 need treatment kind quit smoking 152 p 001 predictive pharmacotherapy usethese findings replicate build upon previous research demonstrating underutilization pharmacotherapy enduring misconceptions pharmacotherapy particularly among black smokers regardless racial group misconceptions pharmacotherapy related lower rates use efforts improve understanding efficacy safety products needed boost utilization impact cessation rates